Tesofensine
Obesity pharmacology, Monoamine reuptake inhibition, Appetite suppression studies, Weight-loss trials
Half-Life
Long; often cited around 9 days for active moieties
Administration
Oral
Frequency
Once Daily, Morning Preferred
How it works
- Obesity pharmacology
- Monoamine reuptake inhibition
- Appetite suppression studies
- Weight-loss trials
Dosing structure
Lower range
0.25–0.5 mg once daily
Higher range
0.25–0.5 mg once daily
Frequency
Once Daily, Morning Preferred
Notes
Long Half-life Means Effects Persist Weeks After Stopping.
Example protocols
Example A
Dose: 0.25–0.5 mg once daily
Frequency: Once Daily, Morning Preferred
Duration: 12-24 weeks
Off period: Not listed
Example B
Dose: 0.25–0.5 mg once daily
Frequency: Once Daily, Morning Preferred
Duration: 12-24 weeks
Off period: Not listed
Protocol Notes
•
Long half-life means effects persist weeks after stopping.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.